Chaudhary, Nayan
Chibly, Alejandro M.
Collier, Ann
Martinalbo, Jorge
Perez-Moreno, Pablo
Moore, Heather M. http://orcid.org/0000-0002-7098-3888
Luhn, Patricia
Metcalfe, Ciara
Hafner, Marc http://orcid.org/0000-0003-1337-7598
Article History
Received: 26 June 2023
Accepted: 4 January 2024
First Online: 22 February 2024
Competing interests
: The authors declare no Competing Non-Financial Interests but the following Competing Financial Interests: All authors are employees of Genentech Inc. or Roche and shareholders of Roche.
: Protocol approval for the acelERA BC clinical trial was obtained from an independent ethics committee for each participating site. The trial was performed in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki and every patient gave written informed consent.